SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-029506
Filing Date
2019-05-13
Accepted
2019-05-13 21:46:43
Documents
2
Period of Report
2019-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3010
2 POA DOCUMENT poa.txt EX-24.3_852593 3568
  Complete submission text file 0001209191-19-029506.txt   7955
Mailing Address 340 MADISON AVENUE 19TH FLOOR NEW YORK NY 10173
Business Address 340 MADISON AVENUE 19TH FLOOR NEW YORK NY 10173 212-220-9319
Applied Therapeutics Inc. (Issuer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O APPLIED THERAPEUTICS, INC. 340 MADISON AVENUE, 19TH FLOOR NEW YORK NY 10173
Business Address
Vignola Mark J. (Reporting) CIK: 0001775429 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38898 | Film No.: 19820263